In vitro/in vivo evaluation of gamma-aminobutyric acid-loadedN,N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy

References

• Babič M, Horák D. Poly(N,N-dimethylacrylamide)-based microspheres prepared by heterogeneous polymerizations. Macromol React Eng, 2007;1:86–94.
   Web of Science ®Google Scholar
• Barari M, Abdollahi M, Hemmati M. Synthesis and characterisation of high molecular weight polyacrylamide nanoparticles by inverse-emulsion polymerisation. Iran Polym J, 2011;20(1):65–76.
   Web of Science ®Google Scholar
• Başaran E, Şenel B, Yurtdaş Kırımlıoğlu G, Güven UM, Yazan Y. Ornidazole incorporated chitosan nanoparticles for ocular application. Lat Am J Pharm, 2015;34(6):1180–8.
   Web of Science ®Google Scholar
• Başaran E, Yenilmez E, Berkman MS, Büyükköroğlu G, Yazan Y. Chitosan nanoparticles for ocular delivery of cyclosporine A. J Microencapsul, 2014;31(1):49–57.
   PubMed Web of Science ®Google Scholar
• Bennewitz MF, Saltzman WM. Nanotechnology for delivery of drugs to the brain for epilepsy. Neurotherapeutics, 2009;6(2):323–36.
   PubMed Web of Science ®Google Scholar
• Bhavna S, Ali M, Baboota S, Sahni JK, Bhatnagar A, Ali J. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm, 2014;40(2):278–87.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Schachter SC, Kwan PKL. 2008. Epilepsy (Fast Facts). Abingdon, USA: Health Press Ltd.
   Google Scholar
• Calvo P, Gouritin B, Chacun H, Desmaële D, D’Angelo J, Noel J, Georgin D, Fattal E, Andreux JP, Couvreur P. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res, 2001;18(8):1157–66.
   PubMed Web of Science ®Google Scholar
• Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm, 2005;304:231–8.
   PubMed Web of Science ®Google Scholar
• CUSABIO®. 2014. Rat gamma-aminobutyric acid (GABA) ELISA Kit Sheet (CSB-E08368r). China: Wuhan Hi-tech Medical Devices.
   Google Scholar
• Dhana LP, Rahul NCM, Venkatkrishnakiran P. Solid lipid nanoparticle systems for delivery of drugs to the brain. Int J Biopharm, 2012;3(2):70–7.
   Google Scholar
• Dichi E, Sghaier M, Fraisse B, Bonhomme F. Physico-chemical characterization of γ-amino n-butyric acid nanoparticles. Chem Pharm Bull, 2011;59(6):703–9.
   PubMed Web of Science ®Google Scholar
• ESAINC®. 2014. Glutamate and GABA analysis application note. USA: ESA Company.
   Google Scholar
• Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm, 1998;168:221–9.
   Web of Science ®Google Scholar
• Gepdiremen A, Sönmez S, Kızıltunç A, İkbal M, Erman F, Düzenli S. Effects of norepinephrine on NMDA-induced neurotoxicity in cerebellar granular cell culture of rat pups. Fundam Clin Pharmacol, 1988;12:517–20.
   Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems – A review (Part1). Trop J Pharm Res, 2013;12(2):255–64.
   Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, Jiang X. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations. J Control Release, 2009;134:55–61.
   PubMed Web of Science ®Google Scholar
• ICH Topic Q2B. 1996. Validation of analytical procedures: Methodology. The European Agency for the evaluation of medicinal products. CPMP/ICH/281/95, Step 4, Consensus Guideline.
   Google Scholar
• Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, Bueno-Junior LS, Leite JP. Animal models of epilepsy: Use and limitations. Neuropsychiatr Dis Treat, 2014;10:1693–705.
   PubMed Web of Science ®Google Scholar
• Kaş HS. 2012. Partikül büyüklüğü ve partikül büyüklük dağılımı. In: Gürsoy AZ, ed. Farmasötik Teknoloji Temel Konular ve Dozaj Şekilleri: Aktif Matbaa ve Reklam Hizmetleri, İstanbul, pp. 69–84.
   Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 2001;47:65–81.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, Briesen H, Begley DJ. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res, 2003;20:409–16.
   PubMed Web of Science ®Google Scholar
• Ku S, Yan F, Wang Y, Sun Y, Yang N, Ye L. The blood–brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain. Biochem Biophys Res Co, 2010;394:871–6.
   PubMed Web of Science ®Google Scholar
• Kumari SDC, Tharani CB, Narayanan N, Kumar CS. Formulation and characterisation of methotrexate loaded sodium alginate chitosan nanoparticles. Indian J Res Pharm Biotechnol, 2013;1(6):915–21.
   Google Scholar
• Leyva-Gomez G, Gonzalez-Trujano ME, Lopez-Ruiz E, Couraud PO, Wekslerg B, Romero I, Miller F, Delie F, Allemann E, Quintanar-guerrero D. Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: Behaviour and electroencephalogram. J Pharm Sci, 2014;103:2509–19.
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. Praziquantel-loaded PLGA nanoparticles: Preparation and characterization. J Microencapsul, 2005;22:13–24.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Ohde H, Wai CM, Rodriguez JM. The synthesis of polyacrylamide nanoparticles in supercritical carbon dioxide. Colloid Polym Sci, 2007;285:475–8.
   Web of Science ®Google Scholar
• Onat F. 2008. Epilepsinin Deneysel Modelleri. In: Bora İ, Yeni SN, Gürses C, eds. Epilepsi. İstanbul: Nobel Tıp Kitabevleri, pp. 37–43.
   Google Scholar
• Pagar K, Vavia P. Rivastigmine-loaded l-lactide-depsipeptide polymeric nanoparticles: Decisive formulation variable optimization. Sci Pharm, 2013;81:865–85.
   PubMedGoogle Scholar
• Petroff OAC. GABA and glutamate in the human brain. The Neuroscientist, 2002;8(6):562–73.
   PubMed Web of Science ®Google Scholar
• Qin M, Hah HJ, Kim G, Nie G, Lee YEK, Kopelman R. Methylene blue covalently loaded polyacrylamide nanoparticles for enhanced tumor-targeted photodynamic therapy. Photochem Photobiol Sci, 2011;10:832–41.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev, 2007;29:411–18.
   Web of Science ®Google Scholar
• Rao JP, Geckeler KE. Polymer nanoparticles: Preparation techniques and size-control parameters. Prog Polym Sci, 2011;36:887–913.
   Web of Science ®Google Scholar
• Rubio C, Rubio-Osornico M, Retana-Márquez S, López M, Custodio V, Paz C. In vivo experimental models of epilepsy. Cent Nerv Syst Agents Med Chem, 2010;10:298–309.
   PubMedGoogle Scholar
• Rutala WA, Webere DJ. Healthcare Infection Control Practises Advisory Committee (HICPAC). Guideline for disinfection and sterilisation in healthcare facilities. 2008, pp. 1–158.
   Google Scholar
• Saito Y, Iwata T. Characterisation of hydroxyl groups of highly crystalline-chitin under static tension detected by FT-IR. Carbohydr Polym, 2012;87:2154–9.
   Web of Science ®Google Scholar
• Şahiner T. 2008. Epilepside Temel Mekanizmalar. In: Bora İ, Yeni SN, Gürses C, eds. Epilepsi. İstanbul: Nobel Tıp Kitabevleri, pp. 29–36.
   Google Scholar
• Tırnaksız F. 2009. Sterilizasyon. In: Acartürk F, Ağabeyoğlu İ, Çelebi N, Değim T, Değim Z, Doğanay T, Takka S, Tırnaksız F, eds. Modern Farmasötik Teknoloji. Ankara: Ersa Matbaacılık, pp. 63–89.
   Google Scholar
• Tian X, Lin X, Wei F, Feng W, Huang Z, Wang P, Ren L, Diao Y. Enhanced brain targeting of temozolamide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomed, 2011;6:445–52.
   PubMed Web of Science ®Google Scholar
• Vamecq J, Feutelais Y, Maurois P, Sghaier M, Dichi E, German-Fattal M, Herrenknecht C, Gressens P, Cecchelli R, Dehouck L, et al. Engineering a GABA endowed with pharmacological CNS activity when given by an extracerebral route. Med Chem Res, 2008;18(4):255–67.
   Web of Science ®Google Scholar
• Vino S, Abinaya A, Diva V, Ghosh AR. Controlled release of phenytoin sodium from casein microparticles. Int J Pharm Biol Sci, 2014;5(2):233–41.
   Google Scholar
• Vlerken LE, Vyas TK, Amiji MM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res, 2007;24(8):1405–14.
   PubMed Web of Science ®Google Scholar
• Wang S, Jiang T, Ma M, Hu Y, Zhang J. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting. Int J Pharm, 2010;386:249–55.
   PubMed Web of Science ®Google Scholar
• WHO. 2015. Epilepsy: Aetiogy, epidemiology and prognosis. [online] Available at: http://www.who.int.
   Google Scholar
• Wilson B, Lavanya Y, Priyadarshini SRB, Ramasamy M, Jenita JL. Albumin nanoparticles for the delivery of gabapentin: Preparation, characterization and pharmacodynamic studies. Int J Pharm, 2014;473:73–9.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, Kumar KPS, Parakrishnan N, Suresh B. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm, 2008;70:75–84.
   PubMed Web of Science ®Google Scholar
• Yang W, Lei Z, Hu Y, Chen X, Fu S. Investigation of the thermal properties, nucleation kinetics, and growth of ɣ-aminobutyric acid in aqueous ethanol solution. Ind Eng Chem Res, 2010;49:11170–5.
   Web of Science ®Google Scholar